ACHIEVING MINIMAL DISEASE ACTIVITY AND REMISSION IN PSORIATIC ARTHRITIS PATIENTS TREATED CONTINUOUSLY WITH TNF INHIBITORS FOR 2 YEARS IN THE REAL LIFE

被引：0
|
作者：
Chimenti, M. S. [1 ]
Triggianese, P. [1 ]
Tonelli, M. [1 ]
Conigliaro, P. [1 ]
Gigliucci, G. [1 ]
Novelli, L. [1 ]
Sunzini, F. [1 ]
Perricone, R. [1 ]
机构：
[1] Univ Roma Tor Vergata, Med Sistemi, Rheumatol Allergol & Clin Immunol, Rome, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.2249
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB1026
引用
收藏
页码：1252 / 1253
页数：2
相关论文
共 50 条
  • [1] Minimal Disease Activity and Remission in Psoriatic Arthritis Patients Treated with Anti-TNF-α Drugs
    Perrotta, Fabio Massimo
    Marchesoni, Antonio
    Lubrano, Ennio
    [J]. JOURNAL OF RHEUMATOLOGY, 2016, 43 (02) : 350 - 355
  • [2] OBESITY AND LOWER LIKELIHOOD OF ACHIEVING MINIMAL DISEASE ACTIVITY AND REMISSION IN PSORIATIC ARTHRITIS PATIENTS
    Vallejo-Yague, E.
    Burkard, T.
    Moeller, B.
    Burden, A. M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 860 - 860
  • [3] Predictors of Achieving Remission Among Patients with Psoriatic Arthritis Prescribed TNF Inhibitors
    Ogdie, Alexis
    Palmer, J. Lynn
    Greenberg, Jeffrey D.
    Harrold, Leslie R.
    Solomon, Daniel H.
    Kavanaugh, Arthur
    Kremer, Joel
    Mease, Philip J.
    Curtis, Jeffrey R.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [4] MINIMAL DISEASE ACTIVITY IN REAL LIFE IN PSORIATIC ARTHRITIS
    Ureyen, S. B.
    Solmaz, D.
    Al Asoimi, N.
    Dalkilic, E.
    Can, M.
    Erden, A.
    Ozisler, C.
    Cinar, M.
    Kilic, L.
    Kalyoncu, U.
    Aydin, S. Z.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1600 - 1600
  • [5] Factors Predicting 2 Years of Remission and Low Disease Activity in Rheumatoid Arthritis Patients Treated with TNF-inhibitors
    Conigliaro, Paola
    Triggianese, Paola
    Chimenti, Maria Sole
    Tonelli, Marco
    Sunzini, Flavia
    Kroegler, Barbara
    Perricone, Roberto
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2017, 19 (08): : 467 - 472
  • [6] MINIMAL DISEASE ACTIVITY AMONG PSORIATIC ARTHRITIS PATIENTS IN A REAL-LIFE REGISTRY
    Haraoui, B.
    Rahman, P.
    Bessette, L.
    Baer, P.
    Avina-Zubieta, A.
    Arendse, R.
    Rampakakis, E.
    Psaradellis, E.
    Maslova, K.
    Lehman, A. J.
    Nantel, F.
    Osborne, B.
    Tkaczyk, C.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : 784 - 784
  • [7] Anti-TNFα Discontinuation in Psoriatic Arthritis: Is It Possible After Achieving Minimal Disease Activity?
    Haddad, Amir
    Thavaneswaran, Arane
    Chandran, Vinod
    Gladman, Dafna D.
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S580 - S581
  • [8] Assessment of Response to Treatment, Remission, and Minimal Disease Activity in Axial Psoriatic Arthritis Treated with Tumor Necrosis Factor Inhibitors
    Lubrano, Ennio
    Parsons, Wendy J.
    Perrotta, Fabio Massimo
    [J]. JOURNAL OF RHEUMATOLOGY, 2016, 43 (05) : 918 - 923
  • [9] PROBABILITY OF ACHIEVING LOW DISEASE ACTIVITY OR REMISSION IN SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS TREATED WITH APREMILAST
    Mease, Philip J.
    Behrens, Frank
    Gladman, Dafna D.
    Kavanaugh, Arthur
    Brunori, Michele
    Teng, Lichen
    Guerette, Benoit
    Queiro, Ruben
    Ogdie, Alexis
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 916 - 917
  • [10] Treat-to-target in real-life psoriatic arthritis patients: achieving minimal disease activity with bDMARDs/tsDMARDs and potential barriers
    Ortolan, Augusta
    Lorenzin, Mariagrazia
    Cozzi, Giacomo
    Scagnellato, Laura
    Favero, Marta
    Striani, Giovanni
    Vio, Stefania
    Scapin, Vanna
    De Conti, Giorgio
    Doria, Andrea
    Ramonda, Roberta
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2023, 62
12345